Lane Generational’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,083
Closed -$4.02K 36
2022
Q4
$4.02K Buy
+1,083
New +$4.79K 0.01% 34
2022
Q3
Sell
-1,083
Closed -$6K 35
2022
Q2
$6K Hold
1,083
0.01% 32
2022
Q1
$8K Sell
1,083
-510
-32% -$5K 0.01% 35
2021
Q4
$21K Buy
+1,593
New +$26.3K 0.02% 34

Other funds holding ORTX

Lane Generational's ORTX Position: Q1 2023 in Review

Lane Generational sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2023, closing a stake of 1,083 shares — an estimated $4.02K sold.

Lane Generational first reported a position in ORTX in Q4 2021 and held it in 4 quarters. The position peaked at $21K in Q4 2021. 35 funds tracked by Wall St. Rank hold ORTX as of Q1 2023.

  • Lane Generational reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Lane Generational sold 1,083 Orchard Therapeutics plc American Depositary Shares shares in Q1 2023, an estimated $4.02K.
  • Lane Generational first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2021 and held it in 4 quarters.
  • Lane Generational's Orchard Therapeutics plc American Depositary Shares position peaked at $21K in Q4 2021.
  • 35 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2023.

Based on Lane Generational's 13F filing for Q1 2023, filed 1 May 2023.